Trial intelligence / Profile preview

HuCNS-SC in Geographic Atrophy of AMD

NCT01632527Phase 2Completed

Sponsor
StemCells, Inc.
Start
Jun 2012
Primary completion
Jun 2015
Modality
Stem Cell Therapies
Countries
1
01

Overview

A Phase 2 trial of HuCNS-SC in geographic atrophy (GA), sponsored by StemCells, Inc.. Started Jun 2012; status: completed.

02

Drugs

HuCNS-SC
03

Conditions

geographic atrophy (GA)

Beyond the preview

Go deeper on NCT01632527.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01632527.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call